Cargando…

Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol

OBJECTIVES: Several beneficial effects of resveratrol have already been published. This study evaluated the effect of resveratrol on the hemorheological parameters in patients with heart failure with reduced ejection fraction. METHODS: In our double-blind, placebo-controlled human clinical trial, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gal, Roland, Praksch, Dora, Kenyeres, Peter, Rabai, Miklos, Toth, Kalman, Halmosi, Robert, Habon, Tamas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350166/ https://www.ncbi.nlm.nih.gov/pubmed/32695229 http://dx.doi.org/10.1155/2020/7262474

Ejemplares similares

The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results
por: Gal, Roland, et al.
Publicado: (2021)

Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure
por: Gal, Roland, et al.
Publicado: (2020)

Effects of Moderate Aerobic Exercise Training on Hemorheological and Laboratory Parameters in Ischemic Heart Disease Patients
por: Sandor, Barbara, et al.
Publicado: (2014)

Hemorheological Parameters in Diabetic Patients: Role of Glucose Lowering Therapies
por: Biro, Katalin, et al.
Publicado: (2021)

Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model
por: Riba, Adam, et al.
Publicado: (2017)

Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review
por: Gál, Roland, et al.
Publicado: (2023)

Diet-Dependent and Diet-Independent Hemorheological Alterations in Celiac Disease: A Case-Control Study
por: Szakács, Zsolt, et al.
Publicado: (2020)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats
por: Deres, Laszlo, et al.
Publicado: (2019)

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2021)

Corrigendum: Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2022)

Surgical treatment of heart failure due to giant coronary artery fistula: a case report
por: Sandor, Barbara, et al.
Publicado: (2020)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Impact of home- and center- based physical training program on cardio-metabolic health and IGF-1 level in elderly women
por: Praksch, Dora, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

l-arginine, asymmetric and symmetric dimethylarginine for early outcome prediction in unselected cardiac arrest victims: a prospective cohort study
por: Csiszar, Beata, et al.
Publicado: (2021)

Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia
por: Caprari, Patrizia, et al.
Publicado: (2019)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes
por: Sepp, Róbert, et al.
Publicado: (2022)

Hemorheology and Microvascular Disorders
por: Cho, Young-Il, et al.
Publicado: (2011)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Management of heart failure with reduced ejection fraction
por: Haydock, Paul M, et al.
Publicado: (2022)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Heart Failure With Preserved Ejection Fraction vs. Reduced Ejection Fraction　― Mechanisms of Ventilatory Inefficiency During Exercise in Heart Failure ―
por: Tsujinaga, Shingo, et al.
Publicado: (2020)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases
por: Jang, Bohyun, et al.
Publicado: (2016)

Amlodipine alters hemorheological parameters: Increased efficacy at the cost of edema?
por: Ravindra, R.P., et al.
Publicado: (2019)

Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
por: Zhang, Beijian, et al.
Publicado: (2021)

Modulation of Mitochondrial Quality Control Processes by BGP-15 in Oxidative Stress Scenarios: From Cell Culture to Heart Failure
por: Horvath, Orsolya, et al.
Publicado: (2021)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_674760ftjjrg7npsurr19goshk